The short version of Certificate of analysis fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-05-07 and is reviewed periodically as new material appears.
Semax is normally supplied as a lyophilized powder, and that form is the most stable. Suppliers commonly recommend storage at -20 °C in a desiccated container protected from light, with short-term handling at room temperature limited to weighing and transfer. Powder that has absorbed moisture degrades faster, so vials should be warmed to ambient temperature before opening to prevent condensation on the contents. Hygroscopic behavior is typical of short hydrophilic peptides, and humidity control matters more than temperature alone for long-term retention.
Once dissolved, the peptide is considerably less stable than the solid. Aqueous solutions are usually prepared at neutral to slightly acidic pH, filtered, and divided into single-use aliquots before freezing. Repeated freeze-thaw cycles are a common cause of avoidable loss and are best prevented by never refreezing a thawed aliquot. Adsorption to plastic and glass surfaces can lower the measured concentration of dilute solutions, particularly below roughly 0.1 mg/mL. Buffer choice, salt content, and container material all influence how much peptide remains detectable after storage.
Semax 是人工设计的七肽，序列为 Met-Glu-His-Phe-Pro-Gly-Pro，骨架取自促肾上腺皮质激素片段 ACTH(4-10)。它于二十世纪八十年代在苏联的分子遗传学研究机构内合成。设计目标是保留该片段与注意力和记忆相关的活性，同时剔除促皮质激素释放等内分泌作用。此后俄罗斯将其登记为药品并进入临床使用。
当时的短肽研究普遍关注能否穿越血脑屏障、在低剂量下产生中枢效应，Semax 属于这一路线。鼻内给药是其主要使用方式，俄语文献报道的适应症涵盖缺血性卒中、短暂性脑缺血发作、认知功能减退以及视神经病变。这些研究大多发表在当地期刊上，样本规模与终点设置同西方试验惯例存在差异，国际同行对其临床证据的强度看法不一。
各国监管态度分化明显。俄罗斯按处方药管理，部分东欧国家留有使用记录；欧盟与美国未批准其作为药物上市，市面流通品通常标注为研究用化学品。身份差异意味着标示含量、纯度与无菌性缺少统一核查。体育领域还牵涉反兴奋剂名录，跨境携带则受目的地药品法规约束。
| Property | Value | Notes |
|---|---|---|
| Solid storage temperature | -20 °C or below | Desiccated and protected from light |
| Solution storage temperature | -80 °C as single-use aliquots | Avoid repeated freeze-thaw cycles |
| Purity assessment method | RP-HPLC, around 214 nm | Reported as main-peak area percent |
| Identity confirmation method | ESI-MS or MALDI-TOF | Measured mass compared with calculated mass |
| Common synonyms | ACTH(4-10) analog; Met-Glu-His-Phe-Pro-Gly-Pro | Also written as Semaxum in some sources |
Published studies examine a fairly narrow set of endpoints. Rodent experiments commonly measure maze learning, infarct volume after induced ischemia, and tissue levels of neurotrophic factors. Clinical reports from Russian centres describe attention, memory and recovery scores in patients after stroke or transient ischemic attack. Most of those human studies are small and few have been repeated by independent groups. Outcome measures differ between studies, which limits direct comparison.
Circulation time for the peptide is short because peptidases cleave it readily. The Pro-Gly-Pro tail is thought to slow breakdown compared with the bare ACTH fragment, but the gain appears modest. Absorption after intranasal dosing is limited, and only a fraction of a dose is expected to reach the central nervous system. Laboratory concentrations therefore sit well above levels achieved systemically, a gap that complicates translation from bench findings to clinical claims.
Later generations of the molecule include an N-acetylated form and an amidated form, both marketed online alongside the parent peptide. These variants differ in terminal chemistry and stability, and they are frequently discussed in the same breath even though they have not been compared in controlled trials. Supply outside formal healthcare systems comes largely from laboratories that synthesize peptides to order. Purity and identity of these materials vary widely, and no single body oversees the international trade.
Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.
Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.
The peptide is prone to several degradation pathways. Oxidation of the methionine residue produces a sulfoxide that elutes close to the parent peak in many chromatographic systems. Hydrolysis of peptide bonds and deamidation of susceptible residues in related sequences also reduce purity over time. Lyophilised material kept dry at minus twenty degrees Celsius and shielded from light is the most stable form commonly described in laboratory practice.
Material sold for laboratory use varies widely in stated purity and documentation. A certificate of analysis should list the analytical method, the column and detector used, and the observed purity value. Independent verification by an outside laboratory is the practical way to confirm identity when documentation is absent or internally inconsistent. Regulatory status differs by country, and a product legal in one jurisdiction may be unapproved or controlled in another.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.
The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.
Empagliflozin, sold under the brand name Jardiance ( JAR-dee-əns), among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes and/or for patients with established heart failure with reduced ejection fraction (HFrEF). Studies have shown great benefits for heart failure (HF) outcomes and decreased hospitalisations. It is taken by mouth. Common side effects of empagliflozin include genital yeast infections and hypotension, particularly in patients with volume depletion. Other symptoms such as nausea and vomiting may occur and seem more pronounced in combination with metformin. Rare but serious adverse events, such as euglycemic diabetic ketoacidosis (DKA) which may present with hyperventilation, lethargy, or mental status changes have been reported but are infrequent in trials. Other serious but rare serious adverse events include Fournier's gangrene, a severe skin infection of the groin, and diabetic ketoacidosis that may occur even with normal blood glucose levels. Use during pregnancy or breastfeeding is not recommended. Empagliflozin is a SGLT2 inhibitor: a reversible inhibitor of the sodium glucose co-transporter-2 (SGLT-2). It reduces the kidney's glucose reabsorption and excretes the excess glucose through the urine, thus its place in the treatment of type two diabetes. It is dependent on blood glucose concentrations and the glomerular filtration rate of the kidney.
==== Organisation ==== 1st Gold Corps - Headquarters in Harbin 1st Gold Detachment 2nd Gold Detachment 3rd Gold Detachment 4th Gold Detachment 2nd Gold Corps 5th Gold Detachment 6th Gold Detachment 7th Gold Detachment 8th Gold Detachment 3rd Gold Corps - Headquarters in Chengdu 9th Gold Detachment 10th Gold Detachment 11th Gold Detachment 12th Gold Detachment Gold Corps Research Institute Gold Corps Training Battalion
== History == The earliest written reference to Croton lechleri dates to the 17th century, when Spanish Jesuit missionary, naturalist, and explorer, Bernabé Cobo encountered the use of the plant's resin by indigenous tribes throughout Mexico, Peru and Ecuador. This discovery was greatly overshadowed in Europe by his description of cinchona bark, or Jesuit's bark, which was instrumental in the discovery and isolation of quinine.
Sources: en.wikipedia.org
Pratt (JP.1), it was entirely due to Collip's expertise that a far less toxic extract from that of Banting and Best's had been produced in just five weeks (p.288). Moreover, he was certain that, without Collip, the Toronto team would never have had an extract that was safe enough to administer to any human being. Also, according to Pratt (pp.286-288), the (pre-Collip) efforts of Banting and Best had been no improvement upon the work of George Ludwig Zuelzer fifteen years earlier: who, despite having been "on the right track" (in relation to recognizing the potential efficacy of a pancreatic extract in the treatment of diabetes mellitus) and, "even with the able assistance of the staff of the Physiological Institute of the University of Berlin as well as that of the trained chemists of the Schering Company over a period of four years [viz., prior to Zuelzer's 1907 publication], had been unable to lessen its toxicity sufficiently to have it employed clinically" (pp.286-288). By 22 February 1922, the Toronto team were reporting that "the effects observed in depancreatized animals have been paralleled in man", that the condition of seven patients had been "favourably influenced" by the daily injection of the extract, and that "the patients themselves report[ed] a subjective subjective sense of well being and increased vigor for a period following the [extract's] administration".
==== Physiological and metabolic consequences ==== OSA in adults is associated with a higher risk for cardiovascular morbidities, diabetes, hypertension, coronary artery disease and stroke – OSA might have a role in the etiology of these conditions. Those conditions may lead to increased mortality that an appropriate treatment for OSA may reduce. OSA is often linked with hypertension as it induces an increase in sympathetic activity that can lead to the elevation of blood pressure. The OSA-related hypercapnia has been suggested to be related to the development of hypertension. Treating the OSA may prevent the development of hypertension. The relationship between OSA and excess body weight is complex, as obesity is more prevalent amongst OSA patients but can also be a risk factor for the development of OSA – it accounts for 58% of adult cases. Thus, both OSA and obesity (when present) may work synergistically and lead to hyperlipidemia, diabetes, insulin resistance and other symptoms of the metabolic syndrome. The metabolic syndrome itself is often associated with OSA: 74–85% of OSA patients are diagnosed with it. CPAP therapy can lead to an improvement of some of the cardiovascular component of the metabolic syndrome while weight loss is also recommended for its positive effects on OSA consequences and metabolic dysfunctions. An intervention comprising exercise and diet is thus effective for the treatment of OSA as it positively impacts the severity of both obesity symptoms and OSA symptoms.
Nevus or naevus (pl. nevi or naevi) is a nonspecific medical term for a visible, circumscribed, chronic lesion of the skin or mucosa. The term originates from naevus, which is Latin for "birthmark"; however, a nevus can be either congenital (present at birth) or acquired. Common terms (mole, birthmark, beauty mark, etc.) are used to describe nevi, but these terms do not distinguish specific types of nevi from one another.
=== Capillary electrophoresis === One significant advancement in the field is the development of integrated capillary electrophoresis (CE) systems on microchips, as demonstrated by Z. Hugh Fan and D. Jed. Harrison. They created a planar glass chip incorporating a sample injector and separation channels using micromachining techniques. This setup allowed for the rapid separation of amino acids in just a few seconds, achieving high separation efficiencies with up to 6800 theoretical plates. The use of high electric fields, possible due to the thermal mass and conductivity of glass, minimized Joule heating effects, making the system highly efficient and fast. Such innovations highlight the potential of microfluidic devices in analytical chemistry, particularly in applications requiring quick and precise analyses.
Sources: en.wikipedia.org
Forensic toxicology is the study of the pharmacodynamics, or what a substance does to the body, and pharmacokinetics, or what the body does to the substance. To accurately determine the effect a particular drug has on the human body, forensic toxicologists must be aware of various levels of drug tolerance that an individual can build up as well as the therapeutic index for various pharmaceuticals. Toxicologists are tasked with determining whether any toxin found in a body was the cause of or contributed to an incident, or whether it was at too low a level to have had an effect. While the determination of the specific toxin can be time-consuming due to the number of different substances that can cause injury or death, certain clues can narrow down the possibilities. For example, carbon monoxide poisoning would result in bright red blood while death from hydrogen sulfide poisoning would cause the brain to have a green hue. Toxicologists are also aware of the different metabolites that a specific drug could break down into inside the body. For example, a toxicologist can confirm that a person took heroin by the presence in a sample of 6-monoacetylmorphine, which only comes from the breakdown of heroin. The constant creation of new drugs, both legal and illicit, forces toxicologists to keep themselves apprised of new research and methods to test for these novel substances. The stream of new formulations means that a negative test result does not necessarily rule out drugs. To avoid detection, illicit drug manufacturers frequently change the chemicals' structure slightly.
NASA engineers had not yet worked out the idiosyncrasies of orbital mechanics involved in rendezvous, which are counter-intuitive. Simply thrusting the spacecraft toward the target changed its orbital altitude and velocity relative to the target. When McDivitt tried this, he found himself moving away and downward, as the retrograde thrust lowered his orbit, increasing his speed. The stage was dumping its residual propellant, causing it to move around in various directions relative to the Gemini. There were only two running lights on the stage, which made it hard at times for McDivitt to determine its orientation. McDivitt concluded that a rendezvous target should have at least three lights. There was no radar on board Gemini 4 to give a precise range to the target, so the astronauts had to rely on their visual depth perception to estimate the range, and this differed for the two men. Initially McDivitt estimated the distance at 400–500 feet (120–150 m), while White believed that it was closer ("a little over 200 feet (61 m)"). At the worst point, McDivitt estimated it was about a half mile (800 meters) away, while White's estimate was three-quarters of a mile (1200 meters). McDivitt estimated that he was able to get as close as 200 feet (61 m), but now White's estimate was between 850 and 1,000 feet (260 and 300 m). After expending almost half his thruster fuel, McDivitt finally gave up, in order to concentrate on the more important EVA objective.
=== Relationships and family === In December 2001, Newsom married legal commentator Kimberly Guilfoyle at Saint Ignatius Catholic Church. They separated in 2004 and jointly filed for divorce in January 2005, citing "difficulties due to their careers on opposite coasts". Their divorce was finalized on February 28, 2006, by which time Guilfoyle was expecting a child with Eric Villency. Guilfoyle gained prominence in 2011 via a Fox News chat show. She was later named senior advisor to Republican president Donald Trump, whom Newsom has extensively criticized, and was later engaged to Donald Trump Jr. In September 2006, Newsom, then 38, briefly dated 19-year-old Brittanie Mountz, a model and restaurant hostess. On January 31, 2007, Newsom's close friend, campaign manager, and former chief of staff Alex Tourk confronted him after learning from his wife, Ruby Rippey-Tourk, that she and Newsom had an affair in 2005, when she was Newsom's appointments secretary. Tourk immediately resigned. Newsom admitted to the affair the next day and apologized to the public, saying he was "deeply sorry" for his "personal lapse of judgment". In 2018, Rippey-Tourk said that she thought it wrong to associate Newsom's behavior with the #MeToo movement: "I was a subordinate, but I was also a free-thinking, 33-yr old adult married woman and mother. I do want to make sure that the #metoo movement is reserved for cases and situations that deserve it." Newsom began dating film director Jennifer Siebel in October 2006. He announced he would seek treatment for alcohol use disorder in February 2007.
Ollie captures her and withholds her Joy, forcing her to remember that she had helped the Germans during the Very Bad Thing. Both aware of the city's true history, Ollie informs her that the city's food has run out and implores her to help him reveal these truths to save the people. Victoria agrees, but when Ollie releases her, she attacks him and escapes. After finding the town's executive committee too addled on Joy to pay any mind to the tanks or the famine, Ollie decides to confront Uncle Jack (Julian Casey), Wellington Wells' friendly celebrity propagandist. Ollie infiltrates his broadcasting studio above City Hall, but he finds the studio is abandoned and Jack is missing. He plays a tape of his final but unreleased broadcast, in which Jack suffers an emotional breakdown brought about by resurfacing memories of his daughter Margaret and despairs over the town's hopeless situation. Ollie finally realizes that Margaret was actually Jack's daughter; Jack had tried to hide her from the Germans, but Ollie (who was their neighbor and hated Jack for being a collaborator) informed on them, and she was shot trying to flee. Now willing to atone, Ollie broadcasts the unreleased tape to the city, awakening the population. He then bids farewell to Margaret and builds a hot air balloon that he rides out of Wellington Wells.
In February 2025, Bukele offered Secretary of State Rubio to accept non-Salvadoran deportees from the United States, including convicted American prisoners "of U.S. citizenship and legal residents". Rubio described the offer as the "most unprecedented and extraordinary migratory agreement anywhere in the world". Bukele stated that these "dangerous American criminals" would be incarcerated in CECOT. In March 2025, the United States deported 238 alleged members of the Venezuelan gang Tren de Aragua to El Salvador. Bukele met Trump in the Oval Office in April 2025 where they discussed immigration. Both Trump and Bukele stated they could not unilaterally release Kilmar Abrego Garcia, a migrant deported due to an administrative error.
Sources: en.wikipedia.org
Each freeze-thaw cycle can degrade a fraction of the peptide and promote aggregation. Dividing a stock solution into single-use volumes removes repeated cycling as a variable. It also limits the time a thawed solution spends at room temperature.
A high main-peak percentage says little about identity, counter-ion content, or residual solvents. It also does not distinguish an isomer or a closely eluting analog. Mass confirmation and the accompanying documentation cover those gaps.
Salt form changes mass, solubility, and hygroscopicity, and acetate and trifluoroacetate salts behave differently in solution. Storage guidance still centers on -20 °C for powder and lower temperatures for solutions. The certificate should state which salt is present.
不存在。它是依据 ACTH 的一段序列人工设计的分子，天然蛋白质中找不到与之完全相同的七肽。名称属于研究代号，而非天然物质名。